Skip to main content
Clinical Trials/JPRN-UMIN000050729
JPRN-UMIN000050729
Recruiting
未知

Whole genome analysis in patients with resected non-small cell lung cancer (WJOG16622L) - Whole genome analysis for non-small cell lung cancer (WJOG16622L)

West Japan Oncology Group0 sites200 target enrollmentMarch 31, 2023

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
West Japan Oncology Group
Enrollment
200
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 31, 2023
End Date
June 14, 2031
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\) Localized or systemically active infection requiring treatment. 2\) Pregnant women, lactating women, women who may be currently pregnant, or cases of unwillingness to use contraception. 3\) Clinically problematic psychiatric disorders precluding enrollment. 4\) Requirement of continuous systemic administration of steroid, and the current use of an immunosuppressant. 5\) History of severe hypersensitivity 6\) History of interstitial lung disease, drug\-induced interstitial lung disease, idiopathic pulmonary fibrosis, radiation pneumonitis requiring steroid therapy, or active interstitial lung disease. 7\) Others judged by the investigator to be unsuitable for this study.

Outcomes

Primary Outcomes

Not specified

Similar Trials